Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPN171H (Simmerafil) dose-exploring study in erectile dysfunction
NCT04479917Phase 2Completed
- Sponsor
- Vigonvita Life Sciences
- Start
- Jul 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TPN171H in erectile dysfunction (ED), sponsored by Vigonvita Life Sciences. Started Jul 2020; status: completed.
02
Drugs
TPN171H
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT04479917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479917.